Tags |
|
|
E-Folder - Should You Attempt Venture Capital?
Raising money takes time and in a super competitive and fas
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
t growing industry the kind the Venture Capitalists like, t
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
me is what you do not have. There is little time in an indu
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
try that grows at the speed of thought. Likewise if you spe
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
t time finding customers, corporate partners and taking ord
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
rs or raising money from your vendors you may not need the
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
oney anyway.
Of course with those truths aside and if you
Of course with those truths aside and if you
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ave not fallen in love with your entrepreneurial baby, you
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ight wish to consider venture capital so you can scream int
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
the future like a lightening bolt. Do I recommend VC fundi
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
g? Some times, but more often not.
When it is appropriate
When it is appropriate
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
to UOPM Use Other Peoples Money and when you yourself are i
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
it only to make money on three-five year in and out deal.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ith three years looking at going public or partnering or be
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ng absorbed by a bigger corporate fish, then yes I say go f
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
r it and get your butt to the coffee shops in Palo Alto and
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
a have fire storm chat with the VC executives with attentio
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
spans of a fly.
If you cannot handle that level of rapid
If you cannot handle that level of rapid
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ire discussion, you are not really VC Material anyway and y
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
u need to look for other options. Consider all this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/46634/e-folder-Should-You-Attempt-Venture-Capital.html">Should You Attempt Venture Capital?</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/46634/e-folder-Should-You-Attempt-Venture-Capital.html]Should You Attempt Venture Capital?[/url]
Related Articles:
Have You Heard The One About Google Taking Over Double Click!
Simple Commonsense Methods That Could Double or Triple your Cold Calling Results
Bookmark it:
|